Suchergebnisse - "John, Katharina"

PubPharm (35)

1

A slow-fast trait continuum at the whole community level in relation to land-use intensification

enthalten in: Nature communications | 2024

von Neyret, M. | Le Provost, G. | Boesing, A. | +50

2

A fast-slow trait continuum at the level of entire communities

enthalten in: bioRxiv.org | 2023

von Neyret, M. | Le Provost, G. | Boesing, A. | +50

3

Hepatokine-based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2023

von Franck, M. | John, K. | Al Aoua, S. | +6

4

Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application

enthalten in: Journal of autoimmunity | 2023

von Henschel, P. | Landwehr-Kenzel, S. | Engels, N. | +12

5

Hepatokine‐based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients

enthalten in: Liver International | 2023

von Franck, M. | John, K. | Al Aoua, S. | +6

6

Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4

enthalten in: Journal of clinical medicine | 2022

von John, K. | Franck, M. | Al Aoua, S. | +8

7

Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features

enthalten in: British journal of haematology | 2022

von Richter, J. | John, K. | Staiger, A. | +13

CommentIn: Br J Haematol. 2022 Feb;196(3):468-470. - PMID 34725813

8

Epstein–Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features

enthalten in: British Journal of Haematology | 2022

von Richter, J. | John, K. | Staiger, A. | +13

9

BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treatment

enthalten in: Cell death & disease | 2021

von Busche, S. | John, K. | Wandrer, F. | +6

10

The TNFR1 antagonist atrosimab is therapeutic in mouse models of acute and chronic inflammation

enthalten in: Frontiers in immunology | 7 July 2021

von Richter, F. | Williams-Fairless, S. | John, K. | +15